Ardelyx, Inc.

Ardelyx, Inc.verified

ARDX

Price:

$6.585

Market Cap:

$1.53B

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or hear...[Read more]

Industry

Biotechnology

IPO Date

2014-06-19

Stock Exchange

NASDAQ

Ticker

ARDX

The PE Ratio as of April 2024 (TTM) for Ardelyx, Inc. (ARDX) is -21.95

According to Ardelyx, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -21.95. This represents a change of -4768.82% compared to the average of 0.47 of the last 4 quarters.

Ardelyx, Inc. (ARDX) Historical PE Ratio (quarterly & annually)

How has ARDX PE Ratio performed in the past?

The mean historical PE Ratio of Ardelyx, Inc. over the last ten years is -12.46. The current -21.95 PE Ratio has changed 17.52% with respect to the historical average. Over the past ten years (40 quarters), ARDX's PE Ratio was at its highest in in the September 2014 quarter at 882.09. The PE Ratio was at its lowest in in the December 2014 quarter at -21.98.

Quarterly (TTM)
Annual

Average

-12.46

Median

-5.62

Minimum

-60.23

Maximum

-0.72

Ardelyx, Inc. (ARDX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ardelyx, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 828.55%

Maximum Annual PE Ratio = -0.72

Minimum Annual Increase = -88.21%

Minimum Annual PE Ratio = -60.23

Quarterly (TTM)
Annual
YearPE RatioChange
2023-20.58205.86%
2022-6.73828.55%
2021-0.72-88.21%
2020-6.1520.49%
2019-5.10362.72%
2018-1.10-77.35%
2017-4.87-4.00%
2016-5.07-63.80%
2015-14.00-76.75%
2014-60.23109.98%

Ardelyx, Inc. (ARDX) Average PE Ratio

How has ARDX PE Ratio performed in the past?

The current PE Ratio of Ardelyx, Inc. (ARDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-9.35

5-year avg

-7.86

10-year avg

-12.46

Ardelyx, Inc. (ARDX) PE Ratio vs. Peers

How is ARDX’s PE Ratio compared to its peers?

Ardelyx, Inc.’s PE Ratio is less than BioLineRx Ltd. (-0.75), less than Lexicon Pharmaceuticals, Inc. (-2.47), less than Seres Therapeutics, Inc. (-0.72), less than ImmunityBio, Inc. (-5.87), less than Zura Bio Limited (0), less than Hepion Pharmaceuticals, Inc. (-1.62), less than AVROBIO, Inc. (-0.13), less than Verastem, Inc. (4.12), less than Mereo BioPharma Group plc (-3.07), less than Terns Pharmaceuticals, Inc. (-12.34), less than PDS Biotechnology Corporation (-3.98), less than Inozyme Pharma, Inc. (-2.28), less than HOOKIPA Pharma Inc. (-3.96), less than null (-0.90),

Build a custom stock screener for Ardelyx, Inc. (ARDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ardelyx, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ardelyx, Inc. (ARDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ardelyx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Ardelyx, Inc.'s PE Ratio?

How is the PE Ratio calculated for Ardelyx, Inc. (ARDX)?

What is the highest PE Ratio for Ardelyx, Inc. (ARDX)?

What is the 3-year average PE Ratio for Ardelyx, Inc. (ARDX)?

What is the 5-year average PE Ratio for Ardelyx, Inc. (ARDX)?

How does the current PE Ratio for Ardelyx, Inc. (ARDX) compare to its historical average?